Literature DB >> 1755673

Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression.

H C Urschel1, M A Razzuk.   

Abstract

For years, patients with "effort" thrombosis were treated by anticoagulants and conservative exercise; and if recurrent symptoms developed when they returned to work, they were considered for first-rib resection. Recently, use of thrombolytic agents with early surgical decompression of the neurovascular compression has markedly reduced morbidity, such as postphlebitic syndrome and the necessity for thrombectomy. A review of 67 patients seen over 25 years showed that 34 were initially treated with heparin sodium and then Coumadin (crystalline warfarin sodium). Recurrent symptoms developed in 21 after they returned to work and necessitated transaxillary first-rib resection to relieve symptoms. Eight also underwent thrombectomy. Recently, 33 patients were initially treated with thrombolytic agents and heparin, followed promptly by early first-rib resection. The evaluation and efficacy of this therapy have been established by frequent and repetitive venograms and careful follow-up of patients. Most of the patients showed improvement with thrombolytic agents. Remaining stenoses that suggested intravascular thrombosis were usually secondary to external compression of the vein by the clavicle, costoclavicular ligament, rib, or scalenus anterior muscle. Venous thrombectomy was necessary in only 4 patients in whom the clot was not controlled by thrombolytic therapy and operative release of compression. There were no deaths in the series.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755673     DOI: 10.1016/0003-4975(91)90004-a

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Harold Clifton Urschel, Jr., MD, LLD(HON), DS(HON): a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Harold Clifton Urschel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

2.  Effort thrombosis: effective treatment with vascular stent after unrelieved venous stenosis following a surgical release procedure.

Authors:  G S Cohen; L Braunstein; D S Ball; F Domeracki
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

3.  [Thoracic outlet syndrome. A study of 45 cases treated between 1975 and 1993].

Authors:  A G Graftiaux; P Kehr
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-10

4.  [Rare combination of causes in thoracic inlet syndrome].

Authors:  I Porokhovnikov; S Venth; T Kroeßner; A Kebsch; T Lesser
Journal:  Chirurg       Date:  2017-05       Impact factor: 0.955

Review 5.  Endovascular Therapy for Central Venous Thrombosis.

Authors:  Adam M Gwozdz; Justinas Silickas; Alberto Smith; Prakash Saha; Stephen A Black
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

6.  Thoracic outlet syndrome: a controversial clinical condition. Part 1: anatomy, and clinical examination/diagnosis.

Authors:  Troy L Hooper; Jeff Denton; Michael K McGalliard; Jean-Michel Brismée; Phillip S Sizer
Journal:  J Man Manip Ther       Date:  2010-06

7.  Thoracic outlet syndrome: a 50-year experience at Baylor University Medical Center.

Authors:  Harold C Urschel; Harry Kourlis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

8.  Unique treatment regimen for effort thrombosis in the nondominant extremity of an overhead athlete: a case report.

Authors:  Dale Snead; Kevin M Marberry; Greg Rowdon
Journal:  J Athl Train       Date:  2009 Jan-Feb       Impact factor: 2.860

9.  Comprehensive management of subclavian vein effort thrombosis.

Authors:  Robert W Thompson
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

10.  Clinical Usefulness of Hybrid Intervention for the Treatment of Primary Thrombosis of Axillary-subclavian Vein.

Authors:  Shiro Onozawa; Hiroyuki Tajima; Satoru Murata; Ken Nakazawa; Tsuyoshi Fukunaga
Journal:  Ann Vasc Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.